During the past decade, UT Southwestern/Simmons Cancer Center-Dallas conducted 275 clinical trials. In the 10-year time frame, 275 clinical trials started and 205 clinical trials were completed, i.e. on average, 74.5% percent of trials that started reached the finish line to date. In the past 5 years, 116 clinical trials started and 110 clinical trials were completed. i.e. 94.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UT Southwestern/Simmons Cancer Center-Dallas" #1 sponsor was "National Cancer Institute (NCI)" with 203 trials, followed by "Children's Oncology Group" with 155 trials sponsored, "Gynecologic Oncology Group" with 56 trials sponsored, "SWOG Cancer Research Network" with 40 trials sponsored and "Alliance for Clinical Trials in Oncology" with 40 trials sponsored. Other sponsors include 206 different institutions and companies that sponsored additional 76 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UT Southwestern/Simmons Cancer Center-Dallas" #1 collaborator was "National Cancer Institute (NCI)" with 400 trials as a collaborator, "NRG Oncology" with 52 trials as a collaborator, "SWOG Cancer Research Network" with 16 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator and "Children's Oncology Group" with 10 trials as a collaborator. Other collaborators include 121 different institutions and companies that were collaborators in the rest 85 trials.

According to Clinical.Site data, the most researched conditions in "UT Southwestern/Simmons Cancer Center-Dallas" are "Leukemia" (40 trials), "Lymphoma" (29 trials), "Sarcoma" (28 trials), "Breast Cancer" (26 trials) and "Brain and Central Nervous System Tumors" (25 trials). Many other conditions were trialed in "UT Southwestern/Simmons Cancer Center-Dallas" in a lesser frequency.

Most popular intervention types in "UT Southwestern/Simmons Cancer Center-Dallas" are "Drug" (551 trials), "Other" (268 trials), "Biological" (220 trials), "Procedure" (185 trials) and "Radiation" (168 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (153 trials), "Quality-of-Life Assessment" (86 trials), "Questionnaire Administration" (66 trials), "Computed Tomography" (51 trials) and "Radiation Therapy" (51 trials). Other intervention names were less common.

The vast majority of trials in "UT Southwestern/Simmons Cancer Center-Dallas" are 532 trials for "All" genders, 144 trials for "Female" genders and 24 trials for "Male" genders.

Currently, there are NaN active trials in "UT Southwestern/Simmons Cancer Center-Dallas". 1 are not yet recruiting, 125 are recruiting, 191 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 308 completed trials in UT Southwestern/Simmons Cancer Center-Dallas, 7 suspended trials, and 50 terminated clinical trials to date.

Out of the total trials that were conducted in UT Southwestern/Simmons Cancer Center-Dallas, 98 "Phase 1" clinical trials were conducted, 336 "Phase 2" clinical trials and 255 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 33 trials that are defined as “Not Applicable".